HOT HMV 2: A Phase 4 Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions

COPD Exacerbation

Interventions

OTHER

Observational Group

Those requiring NIV following an acute exacerbation of COPD

Trial Locations (1)

Guys and St Thomas NHS Foundation, London

All Listed Sponsors

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT04272879 - HOT HMV 2: A Phase 4 Study | Biotech Hunter | Biotech Hunter